CytomX Therapeutics to Present at Upcoming December Investor Conferences
Provided By GlobeNewswire
Last update: Nov 25, 2025
SOUTH SAN FRANCISCO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will participate in the following investor conferences in December.
Read more at globenewswire.com
